Question 1

What are the potential benefits of this combination treatment compared to standard options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the HDR Brachytherapy Plus Stereotactic Ablative Prostate Radiotherapy for Patients With Intermediate and High-risk Prostate Cancer clinical trial (NCT04523896). Contact the study team or your healthcare provider for specific answers.

Question 2

How will my specific prostate cancer characteristics affect my eligibility for this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the HDR Brachytherapy Plus Stereotactic Ablative Prostate Radiotherapy for Patients With Intermediate and High-risk Prostate Cancer clinical trial (NCT04523896). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the HDR Brachytherapy Plus Stereotactic Ablative Prostate Radiotherapy for Patients With Intermediate and High-risk Prostate Cancer clinical trial (NCT04523896). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for treatment sessions?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the HDR Brachytherapy Plus Stereotactic Ablative Prostate Radiotherapy for Patients With Intermediate and High-risk Prostate Cancer clinical trial (NCT04523896). Contact the study team or your healthcare provider for specific answers.

Question 5

What kind of monitoring will be done during and after the treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the HDR Brachytherapy Plus Stereotactic Ablative Prostate Radiotherapy for Patients With Intermediate and High-risk Prostate Cancer clinical trial (NCT04523896). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any additional costs or logistical issues I should be aware of if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the HDR Brachytherapy Plus Stereotactic Ablative Prostate Radiotherapy for Patients With Intermediate and High-risk Prostate Cancer clinical trial (NCT04523896). Contact the study team or your healthcare provider for specific answers.

What this study is about